SPONSOR
Guangdong Provincial People's Hospital
Total Trials
5
Recruiting
5
Phases
Phase 2, Phase 3
Conditions studied: Blood PressureHepatocellular CarcinomaAdverse EventPeritoneal DialysisModerate-to-severe PruritusChronic Kidney Disease-associated ItchNon-Small Cell Lung CancerRET Driver MutationBRAF V600 MutationErb-B2 Receptor Tyrosine Kinase Exon 20 Mutation
NCT04212468
Recruiting
Home Blood Pressure Monitoring Registration Study in the Elderly(HOME Study)
Blood Pressure
NCT05954897 Phase 2
Recruiting
Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma
NCT07098351
Recruiting
Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis
Adverse Event
NCT05800340 Phase 2
Recruiting
Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC
Non-Small Cell Lung Cancer
NCT06533384 Phase 3
Recruiting
PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC
Triple-negative Breast Cancer